These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25204580)

  • 1. Mooreamide A: a cannabinomimetic lipid from the marine cyanobacterium Moorea bouillonii.
    Mevers E; Matainaho T; Allara' M; Di Marzo V; Gerwick WH
    Lipids; 2014 Nov; 49(11):1127-32. PubMed ID: 25204580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo.
    Brizzi A; Brizzi V; Cascio MG; Corelli F; Guida F; Ligresti A; Maione S; Martinelli A; Pasquini S; Tuccinardi T; Di Marzo V
    J Med Chem; 2009 Apr; 52(8):2506-14. PubMed ID: 19331413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics.
    Di Marzo M; Casapullo A; Bifulco G; Cimino P; Ligresti A; Di Marzo V; Riccio R; Gomez-Paloma L
    J Pept Sci; 2006 Sep; 12(9):575-91. PubMed ID: 16534762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
    Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S
    J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinomimetic lipid from a marine cyanobacterium.
    Gutiérrez M; Pereira AR; Debonsi HM; Ligresti A; Di Marzo V; Gerwick WH
    J Nat Prod; 2011 Oct; 74(10):2313-7. PubMed ID: 21999614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endocannabinoid system.
    Kilaru A; Chapman KD
    Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
    Ashton JC; Wright JL; McPartland JM; Tyndall JD
    Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of anorexia nervosa with palmitoylethanoamide.
    Scolnick B
    Med Hypotheses; 2018 Jul; 116():54-60. PubMed ID: 29857912
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.
    Richardson D; Pearson RG; Kurian N; Latif ML; Garle MJ; Barrett DA; Kendall DA; Scammell BE; Reeve AJ; Chapman V
    Arthritis Res Ther; 2008; 10(2):R43. PubMed ID: 18416822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.
    Han B; McPhail KL; Ligresti A; Di Marzo V; Gerwick WH
    J Nat Prod; 2003 Oct; 66(10):1364-8. PubMed ID: 14575438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
    Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
    J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological evaluation of pyridone alkaloids on the endocannabinoid system.
    Chicca A; Berg R; Jessen HJ; Marck N; Schmid F; Burch P; Gertsch J; Gademann K
    Bioorg Med Chem; 2017 Nov; 25(22):6102-6114. PubMed ID: 28284861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.
    Whyte LS; Ford L; Ridge SA; Cameron GA; Rogers MJ; Ross RA
    Br J Pharmacol; 2012 Apr; 165(8):2584-97. PubMed ID: 21649637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and isolation of anandamide and other endocannabinoids.
    Hanus LO
    Chem Biodivers; 2007 Aug; 4(8):1828-41. PubMed ID: 17712821
    [No Abstract]   [Full Text] [Related]  

  • 16. The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.
    Chicca A; Marazzi J; Gertsch J
    Br J Pharmacol; 2012 Dec; 167(8):1596-608. PubMed ID: 22646533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do cannabinoid receptors have more than one endogenous ligand?
    Di Marzo V; De Petrocellis L
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural properties and role of the endocannabinoid lipases ABHD6 and ABHD12 in lipid signalling and disease.
    Kind L; Kursula P
    Amino Acids; 2019 Feb; 51(2):151-174. PubMed ID: 30564946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.